Tickers — S

137 tickers
Ranks this page's recent reports by score.
Seadrill Limited
SDRL·Energy
B ★★★Hold
Current$47.29
Target$56.02
Return+18.5%
Aug 24, 2026

Seadrill is a highly disciplined, pure-play deepwater tollbooth poised to harvest massive cash flows from the offshore upcycle, though investors must accept the razor-thin margin of safety resulting from its fair valuation and inherent vulnerability to commodity shocks.

Score
75
StoneCo Ltd.
STNE·Technology
C ★★Sell
Current$9.36
Aug 24, 2026

StoneCo boasts immense cash flow and valuation cheapness protected by buybacks, but investors should exit as the core acquiring moat is cannibalized by PIX and the MSMB credit pivot faces toxic delinquency headwinds.

Score
70
SoundHound AI, Inc.
SOUN·Technology
F Avoid
Current$7.32
Aug 24, 2026

SoundHound's proprietary voice AI and record revenue growth are outweighed by peer overvaluation, heavy roll-up dilution, collapsing gross margins and impending distressed-asset debt.

Score
29
Star Bulk Carriers Corp.
SBLK·Industrials
A ★★★★Buy
Current$30.50
Target$43.10
Return+41.3%
Aug 24, 2026

Star Bulk is an elite, hyper-efficient cash machine offering a massive double-digit dividend yield at a steep valuation discount, though investors must stomach the inherent, unavoidable volatility of the global commodity shipping cycle.

Score
93
Supernus Pharmaceuticals, Inc.
SUPN·Healthcare
A ★★★★Buy
Current$45.85
Target$63.00
Return+37.4%
Aug 24, 2026

Supernus is rapidly transforming from a legacy epilepsy drugmaker into a $2.2 billion diversified CNS powerhouse trading at a severely discounted valuation, though investors must remain hyper-vigilant regarding the profound, complex execution risks inherent in integrating the massive Indivior mega-merger.

Score
85
Steven Madden, Ltd.
SHOO·Consumer Discretionary
B ★★★Hold
Current$45.71
Target$51.00
Return+11.6%
Aug 22, 2026

Steven Madden leverages an unparalleled, agile supply chain and the transformative Kurt Geiger acquisition to drive high-margin DTC growth, though investors must accept a premium valuation that leaves little room for error amid unpredictable U.S. tariff policies and vulnerable wholesale channels.

Score
76
SunocoCorp LLC
SUNC·Energy
A ★★★★Buy
Current$76.70
Target$83.50
Return+8.9%
Aug 22, 2026

SunocoCorp is an unstoppable consolidator of critical energy infrastructure generating explosive cash flows and a heavily covered >5% yield at a deeply discounted valuation, provided management can successfully integrate its massive recent acquisitions without fracturing its highly leveraged balance sheet.

Score
93
Sociedad Química y Minera de Chile S.A.
SQM·Materials
A ★★★★Buy
Current$75.38
Target$105.00
Return+39.3%
Aug 21, 2026

SQM stands as an unassailable, highly profitable force in the global energy transition, trading at a steep discount to peers, though investors must continuously navigate the complex 2031 Codelco ownership transition and persistent lithium spot price volatility.

Score
94
The Scotts Miracle-Gro Company
SMG·Materials
B ★★★Hold
Current$60.94
Target$78.00
Return+28.0%
Aug 19, 2026

Stripped of its disastrous hydroponic distractions, Scotts Miracle-Gro is a massively profitable, cash-generating consumer monopoly trading at a historically cheap forward multiple, though investors must remain hyper-vigilant regarding its elevated debt load and the looming threat of class-action litigation.

Score
79
Tanger Inc.
SKT·Real Estate
B ★★★Hold
Current$38.65
Target$40.34
Return+4.4%
Aug 18, 2026

Tanger successfully leverages a dominant, low-cost physical retail platform and a fortress balance sheet to drive aggressive rent growth, though its elevated valuation premium against historical norms restricts near-term upside and warrants patience for a wider margin of safety.

Score
77
Spire Inc.
SR·Utilities
B ★★★Hold
Current$82.84
Target$93.00
Return+12.3%
Aug 18, 2026

Spire has successfully transformed into a highly predictable, pure-play regulated natural gas utility with a secure ≈4.0% dividend yield, though investors must tolerate the near-term leverage overhang generated by its $2.48 billion Tennessee acquisition.

Score
80
Sotera Health Company
SHC·Healthcare
A ★★★★Buy
Current$18.89
Target$23.03
Return+21.9%
Aug 17, 2026

Sotera Health is the undisputed, highly profitable tollbooth of the global medical device supply chain, offering massive cash flow and secular growth at a discounted valuation, though investors must remain hyper-vigilant regarding residual environmental litigation and isotope supply chain fragility.

Score
85